Lectin switching during dengue virus infection

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1775-1783

  Dejnirattisai, Wanwisa ^a   Webb, Andrew I ^a,e   Chan, Vera ^b   Jumnainsong, Amonrat ^a   Davidson, Andrew ^c   Mongkolsapaya, Juthathip ^a,d   Screaton, Gavin ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; GLYCAN; INTERCELLULAR ADHESION MOLECULE 3; LECTIN; LYMPH NODE SPECIFIC INTERCELLULAR ADHESION MOLECULE 3 GRABBING INTEGRIN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SWITCHING; GLYCOSYLATION; HOST CELL; HUMAN; HUMAN CELL; INSECT CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; SEROTYPE; SUPERNATANT; VIRAL TROPISM; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSECTS; LECTINS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE; VERO CELLS;

EID: 79957483733     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir173     Document Type: Article

References (45)

1. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010; 328:745-8.
2. Duangchinda T, Dejnirattisai W, Vasanawathana S, et al. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A 2010; 107:16922-7.
3. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006; 19:429-36. (Pubitemid 44338101)
4. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921-7. (Pubitemid 36889936)
5. Bozza FA, Cruz OG, Zagne SM, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008; 8:86.
6. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol 1996; 40:569-73. (Pubitemid 26282110)
7. Kou Z, Quinn M, Chen H, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol 2008; 80:134-46. (Pubitemid 350220099)
8. Durbin AP, Vargas MJ, Wanionek K, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 2008; 376:429-35.
9. Chen Y, Maguire T, Hileman RE, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997; 3:866-71. (Pubitemid 27353446)
10. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823-9. (Pubitemid 36437860)
11. Miller JL, de Wet BJ, Martinez-Pomares L, et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 2008; 4:e17.
12. Marianneau P, Megret F, Olivier R, Morens DM, Deubel V. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J Gen Virol 1996; 77:2547-54. (Pubitemid 26348378)
13. Cabrera-Hernandez A, Thepparit C, Suksanpaisan L, Smith DR. Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70. J Med Virol 2007; 79:386-92. (Pubitemid 46355438)
14. Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005; 79:4557-67. (Pubitemid 40464207)
15. Jindadamrongwech S, Thepparit C, Smith DR. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 2004; 149:915-27. (Pubitemid 38641472)
16. Chen YC, Wang SY, King CC. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 1999; 73:2650-7.
17. Lozach PY, Burleigh L, Staropoli I, et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem 2005; 280:23698-708. (Pubitemid 40884852)
18. Navarro-Sanchez E, Altmeyer R, Amara A, et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003; 4:723-8. (Pubitemid 36974759)
19. Sakuntabhai A, Turbpaiboon C, Casademont I, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37:507-13. (Pubitemid 40617279)
20. Chen ST, Lin YL, Huang MT, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008; 453:672-6.
21. Dejnirattisai W, Duangchinda T, Lin C-LS, et al. A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J Immunol 2008; 181:5865-74.
22. Pryor MJ, Azzola L, Wright PJ, Davidson AD. Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly. J Gen Virol 2004; 85:3627-36. (Pubitemid 39591869)
23. Hacker K, White L, de Silva AM. N-linked glycans on dengue viruses grown in mammalian and insect cells. J Gen Virol 2009; 90:2097-106.
24. Chan VS, Chan KY, Chen Y, et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006; 38:38-46. (Pubitemid 43011880)
25. Wu SJ, Grouard-Vogel G, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816-20. (Pubitemid 30469433)
26. van Die I, van Vliet SJ, Nyame AK, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003; 13:471-8. (Pubitemid 36665421)
27. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001; 193:671-8. (Pubitemid 32524461)
28. Cormier EG, Durso RJ, Tsamis F, et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 2004; 101:14067-72. (Pubitemid 39305031)
29. Davis CW, Mattei LM, Nguyen HY, Ansarah-Sobrinho C, Doms RW, Pierson TC. The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J Biol Chem 2006; 281:37183-94. (Pubitemid 46042188)
30. Halary F, Amara A, Lortat-Jacob H, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002; 17:653-64. (Pubitemid 35351510)
31. Marzi A, Gramberg T, Simmons G, et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004; 78:12090-5. (Pubitemid 39390798)
32. Guo Y, Feinberg H, Conroy E, et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004; 11:591-8. (Pubitemid 38823524)
33. Pokidysheva E, Zhang Y, Battisti AJ, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006; 124:485-93. (Pubitemid 43199435)
34. Johnson AJ, Guirakhoo F, Roehrig JT. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 1994; 203:241-9. (Pubitemid 24261750)
35. Lee E, Leang SK, Davidson A, Lobigs M. Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release. J Virol 2010; 84:5171-80.
36. Mondotte JA, Lozach PY, Amara A, Gamarnik AV. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol 2007; 81:7136-48. (Pubitemid 46986649)
37. Beasley DW, Whiteman MC, Zhang S, et al. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1West Nile virus strains. J Virol 2005; 79:8339-47. (Pubitemid 40853537)
38. Newsom-Davis TE, Wang D, Steinman L, et al. Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res 2009; 69:2018-25.
39. Malcherek G, Mayr L, Roda-Navarro P, Rhodes D, Miller N, Trowsdale J. The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN. J Immunol 2007; 179:3804-11.
40. Engering A, van Vliet SJ, Hebeda K, et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am J Pathol 2004; 164: 1587-95. (Pubitemid 38529761)
41. Pohlmann S, Soilleux EJ, Baribaud F, et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 2001; 98:2670-5. (Pubitemid 32209540)
42. Jeffers SA, Tusell SM, Gillim-Ross L, et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2004; 101:15748-53. (Pubitemid 39473559)
43. Jameson B, Baribaud F, Pohlmann S, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76:1866-75. (Pubitemid 34094633)
44. Balsitis SJ, Williams KL, Lachica R, et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010; 6:e1000790.
45. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411-8. (Pubitemid 38543590)